Will Insurers Cover Wegovy and other GLP-1 drugs if Medicare Expands Access?

 October 20, 2025

There is a general truth in the health insurance sector: If Medicare and Medicaid are given the green light to cover a certain drug, insurers in the group health and individual health insurance market usually follow suit.


The Centers for Medicare and Medicaid Services (CMS) typically allows Medicare drug plans and Medicaid to cover a drug once the Food and Drug Administration approves it for specific conditions. However, despite the FDA's approval of popular-yet-pricey GLP-1 drugs like Wegovy, Ozempic, and Zepbound for weight loss, these programs do not cover them due to a long-standing rule not to cover anti-obesity medications (AOMs)


In 2024, CMS issued a proposed rule that would cover AOMs used solely for weight loss.  However, in April 2025, CMS finalized the proposed rule but did not include coverage for AOMs solely for weight loss in the final rule.  CMS stated it would continue to review AOMs and may revisit coverage in the future.


If CMS finalizes the rule, will group health and individual health insurers follow suit? 


Current Medicare GLP-1 coverage


Medicare, through Part D drug plans, and Medicaid already cover GLP-1s for certain conditions, including:

  • Type 2 diabetes, and
  • Cardiovascular disease.
  • Currently, some states cover GLP-1 drugs and AOMs under Medicaid.

 

After the government programs began covering the medications for the above conditions, private insurers have largely done the same.


The drugs approved for these conditions include:

  • Ozempic,
  • Mounjaro,
  • Rybelsus, and
  • Wegovy.

 


The fine print


Experts say that if CMS approves GLP-1s and other AOMs for weight loss, private health insurers would likely do the same. However, this does not mean they would cover them outright. Each plan's copays, deductibles, and coinsurance would still apply, as they do for all other drugs.


The list price of these drugs is around $1,000 a month or more, though some manufacturers offer savings programs that significantly reduce the cost to patients.. Since GLP-1s and AOMs are expensive specialty drugs, insurers would likely put them in their pharmaceutical fee schedule's most expensive tier, meaning that enrollees would pay higher copays and/or coinsurance than for lower-tier drugs.


Additionally, health plans that decide to cover these drugs may require plan enrollees to first try less expensive treatments and/or lifestyle changes before approving a GLP-1 prescription.

 


Effect on costs


The rising cost of specialty drugs are contributing to overall premium inflation.


In 2023, health insurance outlays for prescription drugs increased by 10.8%, compared to 2.6% for all medical expenses, according to the U.S. Department of Health and Human Services. This increase was driven by brand-name and specialty drugs, particularly those used to treat diabetes and weight loss, such as GLP-1 drugs. If more insurers start covering these popular drugs, it would likely affect premiums.


However, there could be offsetting cost benefits. Consider that:

  • These drugs often result in a significant drop in blood-sugar levels, reducing the risk of diabetes-related complications.
  • GLP-1s yield an average weight loss of 15 to 20%, and about one-third of users lose approximately 10% of their body weight, according to a study.
  • Multiple studies have shown that they can reduce the risk of cardiovascular events, including heart attack and stroke.
  • There is growing research to determine if GLP-1s address other health conditions besides diabetes and heart disease. 
  • The drugs may help people cut back on drinking, according to a study published in JAMA.



Conclusion


The future of Wegovy and other GLP-1 weight-loss drugs in Medicare coverage remains uncertain—but if CMS eventually expands access, private insurers will likely follow. Still, high costs, strict utilization rules, and placement in expensive drug tiers could shape how coverage is offered. For patients, this means progress toward broader access is possible, but planning ahead for out-of-pocket costs will remain essential. Staying informed—and working with a trusted advisor—can help you navigate these changes as the coverage landscape continues to evolve.


Patient's hand with an IV line resting on white blankets in a hospital bed
November 18, 2026
A sudden hospital stay leaves families scrambling. Learn how to organize insurance details, appoint a trusted advocate, and create emergency plans.
Older man holding out a crumpled pack of cigarettes toward the camera
November 11, 2026
Discover how Medicare supports older adults with free smoking cessation counseling and annual lung cancer screenings to help reclaim lung health.
Two men talking and smiling while leaning on a railing outside a brick building
November 4, 2026
Loneliness, postpartum depression in dads, and osteoporosis in men rarely make headlines. Learn about overlooked men's health issues and how to help.
Person seated at a table using a smartphone in a cozy living room with bookshelves and framed photos
October 28, 2026
AI can help scammers create convincing images, voices, and documents. Learn the warning signs and simple steps that can help protect your insurance information.
Man in a blue shirt smiling at a glass display counter in a jewelry store
October 21, 2026
More Americans are retiring gradually. Discover how you can plan a phased transition and build financial confidence for the retirement you want.
Children in Halloween costumes trick-or-treating at a decorated house with pumpkins and lit lanterns
October 16, 2026
Keep Halloween safe and fun for the whole family. Use this simple checklist for costumes, pumpkins, trick-or-treating, candy, and driving safety this year.
Assorted colorful pills and capsules scattered in a close-up view
October 14, 2026
A temporary Medicare Part D premium program ends after 2026. Learn what it could mean for your 2027 drug plan costs and coverage.
Smiling person holding a pink awareness ribbon against a gray background
October 7, 2026
Breast Cancer Awareness Month is a reminder to know your normal, discuss screening with your doctor, and understand how your health coverage supports cancer care.
Checklist clipboard with blue health and finance icons, including shield, umbrella, charts, heart, and calendar.
September 23, 2026
Retiring soon? Review seven key financial decisions involving investments, Social Security, Medicare, RMDs and retirement income before you retire.
Smartphone on a wooden table showing an incoming call from “Unknown Caller,” with a coffee mug nearby.
September 16, 2026
Medicare scam calls and fake insurance agents are on the rise. Learn the warning signs, how to verify who you're talking to, and what to do if you share information.
Show More